Every November 14, World Diabetes Day is commemorated as an opportunity to raise awareness of the impact of this disease on people's health. The date also seeks to highlight the opportunities that exist to strengthen the prevention, diagnosis and treatment of diabetes.
The selected theme for this year is "Education to protect for tomorrow". It calls for the need to strengthen access to quality diabetes education both for the health care team and for people living with the disease, their caregivers and society in general.
It is estimated that the number of people living with diabetes worldwide has increased from 108 million to 420 million in the last thirty years; and 62 of these millions are in the Region of the Americas. This figure has more than tripled in the Region since 1980 and could be even higher, as 40% of people with diabetes are unaware of their condition.
Hoy es el #DíaMundialDeLaDiabetes 🔵.— SMC_SaludCuba (@SMC_SaludCuba) November 14, 2022
✊ El tema de este año es “Educación para proteger el mañana”.
La #diabetes afecta a 62 millones de personas en #LasAméricas y va en ⬆️.
Más info 👉https://t.co/R6mzZNrZhf#díasmundiales #diabetesmellitus#diabetes #Heberprot_P #Cuba pic.twitter.com/LdCLORwdH1
The burden of disease associated with diabetes is enormous and growing: in just 20 years, mortality from diabetes has increased by 70% worldwide. In the Region of the Americas, it is the sixth leading cause of death and the seventh leading cause of premature years of life lost.
In Cuba, according to data from the most recent edition of the Health Statistics Yearbook, diabetes is the eighth leading cause of death, with a rate of 34.1 per 100,000 inhabitants. The prevalence is 66.9 per 1,000 inhabitants.
Containing the increase in diabetes is possible and goes hand in hand with implementing strategies focused on prevention, timely diagnosis, monitoring and control of risk factors and possible complications of the disease, and adequate and efficient treatment.
People living with diabetes can suffer numerous neurovascular complications, which are accompanied by high economic and social costs.
Cuban Medical Services offers comprehensive care for diabetics, including the use of the novel and unique drug Heberprot-P®, prescribed for diabetic foot ulcer therapy, supported by the experience of professionals from the Institute of Angiology and Vascular Surgery and the Institute of Endocrinology.
Heberprot-P® is a lyophilized product containing recombinant human epidermal growth factor. It is developed by the Center for Genetic Engineering and Biotechnology and applied by specialized personnel specifically trained in the use of this drug. It is applied to individuals of any age, sex and race, regardless of the type of diabetes. It has been the definitive and effective answer to this health problem.
The medical program consists of an initial evaluation that includes: consultations with specialists, basic and specific complementary investigations, as well as procedures for the preparation of the areas to be treated with the medication (4 days of hospitalization); and, a second stage of drug treatment where the infiltration with Heberprot-P® is performed in the lesions (26 days of hospitalization).
Advantages with the use of Heberprot-P®:
- Stimulates granulation and healing in a progressive and sustained way.
- Reduces the number of debridement and surgical interventions.
- Reduces the number of recurrences.
- Reduces the healing time and with it, the resulting complications, such as gangrene and infection or over-infection, since the wound becomes deeper and more tissue needs to be removed or even amputated.
- Reduces hospital stay costs.
- Increases the patient's quality of life and functional recovery.
- It decreases the chances of infection and allows people to incorporate faster to social life.
To start the treatment, you should contact the Coordination and Processing Center of Comercializadora de Servicios Médicos Cubanos, S.A., at email@example.com.
With information from World Diabetes Day and PAHO.
By: MSc. Dra. Patricia Alonso Galbán
Communication Specialist in CSMC, S.A